Announcements Trials
Browse Landscape

Status

Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Tuberous Sclerosis 1Seizures 1Neoplasms 1Lennox Gastaut Syndrome 1Epilepsies, Myoclonic 1

Interventions

Surveys and Questionnaires 38Blood Specimen Collection 24Specimen Handling 14Radiotherapy 12Surgical Procedures, Operative 10Interviews as Topic 10Observation 9Magnetic Resonance Spectroscopy 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mastectomy, Segmental 5Biopsy 5ribociclib 4palbociclib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Mental Status and Dementia Tests 4Magnetic Resonance Imaging 4Ipilimumab 4Immune Checkpoint Inhibitors 4High-Throughput Nucleotide Sequencing 4Echocardiography 4Bevacizumab 4lorlatinib 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Cannabidiol × Clear all
NCT05485831 2026-06-03

EpiTALY

Jazz Pharmaceuticals

Active not recruiting
111 enrolled

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05836857 2026-04-16

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

M.D. Anderson Cancer Center

Active not recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡